For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
We are looking to recruit a senior team member within the Department of In Vitro Sciences.
In this challenging role, you will take on a Scientific Manager position within the in vitro safety pharmacology group and report to the department head. You will be responsible for leading our in vitro safety pharmacology activities; developing study director teams, running in vitro safety pharmacology tests; developing and implementing a strategy to drive the business forward with new scientific techniques whilst growing business volume. You will work closely with our global in vitro and in vivo safety pharmacology teams.
With a successful track record and significant experience in staff and study management at Study Director level or beyond as well as an experienced report writer, you’ll be able to demonstrate your ability to motivate and develop staff to perform at the highest level. A sound technical background and effective organisational skills are essential as is experience of client facing interactions. A flexible, enthusiastic and energetic attitude is essential to make a success of this role.
In addition, you’ll be particularly involved in supporting the department head in developing business with current and potential external clients, therefore delivering presentations and travel will be a prerequisite of the post.
Applicants should have:-
- Degree in life sciences, a post graduate qualification with a safety pharmacology focus would be advantageous
- Significant laboratory experience in an in vitro safety pharmacology or related role
- Direct experience of leading a group with diverse scientific backgrounds
- Strong written and verbal communication skills
Salary for this position will be on non-graded and dependent upon qualifications and/or relevant experience.
All internal applicants should apply through the careers page on Talent Hub.
Closing Date: September 4th, 2019
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 14,000 employees within 80 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2018, revenue increased by 22% to $2.27 billion from $1.86 billion in 2017.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2018.